• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Deadline Approaching: Apply for the Fierce AI Innovation Awards

Duchenne muscular dystrophy (DMD)

Bubbles in boiling water
Favicon Fierce Biotech

Big Pharma-backed SonoThera sounds off with $125M series B

With a suite of big-name backers and tech built on FDA-approved components, SonoThera aims to revolutionize genetic medicine.
Darren Incorvaia Jun 10, 2026 10:48am
breah of contract lawsuit

With FDA decision date looming, Capricor sues partner NS Pharma

May 8, 2026 11:38am
Roche

Roche to launch another Elevidys study, eying EU approval

Apr 16, 2026 10:06am
sarepta building

Sarepta CEO to retire, citing 'shocking and ironic twist of fate'

Feb 26, 2026 11:30am
Roche

Another setback for Enspryng as Roche halts Duchenne development

Feb 23, 2026 3:40pm
cartoon of man unplugging from outlet

PTC withdraws US approval filing for Duchenne drug Translarna

Feb 13, 2026 10:05am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings